Hyderabad Telangana, India

Shailendra Mandge

USPTO Granted Patents = 4 

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Shailendra Mandge: Innovator in Pharmaceutical Compositions

Introduction

Shailendra Mandge is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid compositions for oral administration. With a total of four patents to his name, Mandge's work is focused on improving the efficacy and stability of pharmaceutical formulations.

Latest Patents

Among his latest patents, Mandge has developed stable pharmaceutical compositions of clonidine. This invention relates to liquid pharmaceutical compositions of clonidine or its pharmaceutically acceptable salts. The compositions are designed for oral administration and are stable for extended periods. Specifically, these stable liquid pharmaceutical compositions of clonidine are provided at concentrations of 1 μg/mL or more. The invention also encompasses methods for administration, processes for production, and the use of these compositions for treating diseases that are responsive to clonidine.

Career Highlights

Shailendra Mandge has worked with reputable companies in the pharmaceutical industry, including Slayback Pharma and Azurity Pharmaceuticals. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Mandge has collaborated with professionals such as Harish Gunda and Naga Venkata Durga Prasad Ketha, enhancing his work through shared knowledge and expertise.

Conclusion

Shailendra Mandge's contributions to pharmaceutical innovations, particularly in stable liquid compositions, highlight his role as a significant inventor in the industry. His work continues to impact the field positively, paving the way for advancements in pharmaceutical formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…